{
  "success": true,
  "pagesUsed": [
    38,
    39,
    40,
    41,
    42
  ],
  "modelUsed": "gemini-3-flash-preview",
  "eligibility": {
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Age requirement",
        "text": "The participant must be 18 to 55 years of age, inclusive, at the time of signing the informed consent.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "RMS Diagnosis",
        "text": "The participant must have been diagnosed with RMS according to the 2017 revision of the McDonald diagnostic criteria (17).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "EDSS Score",
        "text": "The participant has an EDSS score ≤5.5 at the first visit (Screening Visit)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Relapse or MRI Activity",
        "text": "The participant must have at least 1 of the following prior to screening: ≥1 documented relapse within the previous year OR ≥2 documented relapses within the previous 2 years, OR ≥1 documented Gd-enhancing lesion on an MRI scan within the previous year. Note: The initial clinical demyelinating episode of MS should be counted as a relapse for the first 2 criteria.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Sex and Contraception",
        "text": "Male or Female. Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies. Male participants wishing to conceive a child and female participants becoming pregnant or wishing to become pregnant must permanently discontinue the study intervention and follow the local teriflunomide label recommendation. Male participants are eligible to participate if they agree to refrain from donating sperm and be abstinent or use contraception. Female participants must not be pregnant or breastfeeding and must be non-WOCBP or agree to use highly effective contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Informed Consent",
        "text": "The participant must have given written informed consent prior to undertaking any study-related procedure. This includes consent to comply with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "PPMS or nonrelapsing SPMS Diagnosis",
        "text": "The participant has been diagnosed with PPMS according to the 2017 revision of the McDonald diagnostic criteria (17) or with nonrelapsing SPMS (18).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Infection Risk",
        "text": "The participant has a history of infection or may be at risk for infection: history of T-lymphocyte vaccination/transplantation; received live vaccine within 2 months; lymphocyte count < LLN; history of PML; history of HIV; history of active or latent TB; persistent chronic or active recurring infection; fever within 4 weeks; risk of hepatitis B or C; or other active infections.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Psychiatric or Substance Abuse",
        "text": "The presence of psychiatric disturbance or substance abuse as evidenced by: history of psychiatric disease/depression requiring hospitalization within 2 years; documented history of attempted suicide or suicidal ideation (C-SSRS Category 4 or 5) over 6 months; active alcohol use disorder or drug abuse within 1 year; current alcohol intake >2 drinks/day for men and >1 drink/day for women.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Clinically Significant Screening Findings",
        "text": "The following findings obtained during the Screening Visit considered in the Investigator’s judgment to be clinically significant in the context of this clinical trial: Any screening laboratory values outside normal limits; Abnormal ECG.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Bleeding Predisposition",
        "text": "Conditions that may predispose the participant to excessive bleeding: bleeding disorder or known platelet dysfunction; platelet count <150 000/μL; major surgery within 4 weeks; history of significant bleeding event within 6 months (e.g., cerebral or gastrointestinal).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "General Participation Contraindications",
        "text": "Conditions that would adversely affect participation in the study or make the primary efficacy endpoint non-evaluable: Sensitivity to study interventions; short life expectancy due to pre-existing health condition(s).",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "identifier": "I 01",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion",
        "name": "Age requirement",
        "nextId": "ec_2"
      },
      {
        "id": "ec_2",
        "identifier": "I 02",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion",
        "name": "RMS Diagnosis",
        "previousId": "ec_1",
        "nextId": "ec_3"
      },
      {
        "id": "ec_3",
        "identifier": "I 03",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion",
        "name": "EDSS Score",
        "previousId": "ec_2",
        "nextId": "ec_4"
      },
      {
        "id": "ec_4",
        "identifier": "I 04",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion",
        "name": "Relapse or MRI Activity",
        "previousId": "ec_3",
        "nextId": "ec_5"
      },
      {
        "id": "ec_5",
        "identifier": "I 06",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion",
        "name": "Sex and Contraception",
        "previousId": "ec_4",
        "nextId": "ec_6"
      },
      {
        "id": "ec_6",
        "identifier": "I 07",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion",
        "name": "Informed Consent",
        "previousId": "ec_5"
      },
      {
        "id": "ec_7",
        "identifier": "E 01",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion",
        "name": "PPMS or nonrelapsing SPMS Diagnosis",
        "nextId": "ec_8"
      },
      {
        "id": "ec_8",
        "identifier": "E 02",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion",
        "name": "Infection Risk",
        "previousId": "ec_7",
        "nextId": "ec_9"
      },
      {
        "id": "ec_9",
        "identifier": "E 03",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion",
        "name": "Psychiatric or Substance Abuse",
        "previousId": "ec_8",
        "nextId": "ec_10"
      },
      {
        "id": "ec_10",
        "identifier": "E 04",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion",
        "name": "Clinically Significant Screening Findings",
        "previousId": "ec_9",
        "nextId": "ec_11"
      },
      {
        "id": "ec_11",
        "identifier": "E 05",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion",
        "name": "Bleeding Predisposition",
        "previousId": "ec_10",
        "nextId": "ec_12"
      },
      {
        "id": "ec_12",
        "identifier": "E 06",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion",
        "name": "General Participation Contraindications",
        "previousId": "ec_11"
      }
    ],
    "summary": {
      "inclusionCount": 6,
      "exclusionCount": 6,
      "totalCount": 12
    },
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12"
      ],
      "instanceType": "StudyDesignPopulation",
      "description": "Target population defined by eligibility criteria"
    }
  },
  "rawResponse": {
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "name": "Age requirement",
        "identifier": "I 01",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_2",
        "name": "RMS Diagnosis",
        "identifier": "I 02",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_3",
        "name": "EDSS Score",
        "identifier": "I 03",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_4",
        "name": "Relapse or MRI Activity",
        "identifier": "I 04",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_5",
        "name": "Sex and Contraception",
        "identifier": "I 06",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_6",
        "name": "Informed Consent",
        "identifier": "I 07",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_7",
        "name": "PPMS or nonrelapsing SPMS Diagnosis",
        "identifier": "E 01",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_8",
        "name": "Infection Risk",
        "identifier": "E 02",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_9",
        "name": "Psychiatric or Substance Abuse",
        "identifier": "E 03",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_10",
        "name": "Clinically Significant Screening Findings",
        "identifier": "E 04",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_11",
        "name": "Bleeding Predisposition",
        "identifier": "E 05",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_12",
        "name": "General Participation Contraindications",
        "identifier": "E 06",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion"
      }
    ],
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Age requirement",
        "text": "The participant must be 18 to 55 years of age, inclusive, at the time of signing the informed consent.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "RMS Diagnosis",
        "text": "The participant must have been diagnosed with RMS according to the 2017 revision of the McDonald diagnostic criteria (17).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "EDSS Score",
        "text": "The participant has an EDSS score ≤5.5 at the first visit (Screening Visit)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Relapse or MRI Activity",
        "text": "The participant must have at least 1 of the following prior to screening: ≥1 documented relapse within the previous year OR ≥2 documented relapses within the previous 2 years, OR ≥1 documented Gd-enhancing lesion on an MRI scan within the previous year. Note: The initial clinical demyelinating episode of MS should be counted as a relapse for the first 2 criteria.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Sex and Contraception",
        "text": "Male or Female. Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies. Male participants wishing to conceive a child and female participants becoming pregnant or wishing to become pregnant must permanently discontinue the study intervention and follow the local teriflunomide label recommendation. Male participants are eligible to participate if they agree to refrain from donating sperm and be abstinent or use contraception. Female participants must not be pregnant or breastfeeding and must be non-WOCBP or agree to use highly effective contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Informed Consent",
        "text": "The participant must have given written informed consent prior to undertaking any study-related procedure. This includes consent to comply with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "PPMS or nonrelapsing SPMS Diagnosis",
        "text": "The participant has been diagnosed with PPMS according to the 2017 revision of the McDonald diagnostic criteria (17) or with nonrelapsing SPMS (18).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Infection Risk",
        "text": "The participant has a history of infection or may be at risk for infection: history of T-lymphocyte vaccination/transplantation; received live vaccine within 2 months; lymphocyte count < LLN; history of PML; history of HIV; history of active or latent TB; persistent chronic or active recurring infection; fever within 4 weeks; risk of hepatitis B or C; or other active infections.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Psychiatric or Substance Abuse",
        "text": "The presence of psychiatric disturbance or substance abuse as evidenced by: history of psychiatric disease/depression requiring hospitalization within 2 years; documented history of attempted suicide or suicidal ideation (C-SSRS Category 4 or 5) over 6 months; active alcohol use disorder or drug abuse within 1 year; current alcohol intake >2 drinks/day for men and >1 drink/day for women.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Clinically Significant Screening Findings",
        "text": "The following findings obtained during the Screening Visit considered in the Investigator’s judgment to be clinically significant in the context of this clinical trial: Any screening laboratory values outside normal limits; Abnormal ECG.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Bleeding Predisposition",
        "text": "Conditions that may predispose the participant to excessive bleeding: bleeding disorder or known platelet dysfunction; platelet count <150 000/μL; major surgery within 4 weeks; history of significant bleeding event within 6 months (e.g., cerebral or gastrointestinal).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "General Participation Contraindications",
        "text": "Conditions that would adversely affect participation in the study or make the primary efficacy endpoint non-evaluable: Sensitivity to study interventions; short life expectancy due to pre-existing health condition(s).",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "plannedEnrollmentNumber": {
        "maxValue": 162,
        "instanceType": "Range"
      },
      "plannedMinimumAge": "P18Y",
      "plannedMaximumAge": "P55Y",
      "plannedSex": [
        {
          "code": "Male",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Male"
        },
        {
          "code": "Female",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Female"
        }
      ],
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12"
      ],
      "instanceType": "StudyDesignPopulation"
    }
  }
}